201 related articles for article (PubMed ID: 33321450)
21. External validation of the CAPRA-S score to predict biochemical recurrence, metastasis and mortality after radical prostatectomy in a European cohort.
Tilki D; Mandel P; Schlomm T; Chun FK; Tennstedt P; Pehrke D; Haese A; Huland H; Graefen M; Salomon G
J Urol; 2015 Jun; 193(6):1970-5. PubMed ID: 25498570
[TBL] [Abstract][Full Text] [Related]
22. A novel nomogram provides improved accuracy for predicting biochemical recurrence after radical prostatectomy.
Xia HZ; Bi H; Yan Y; Yang B; Ma RZ; He W; Zhu XH; Zhang ZY; Zhang YT; Ma LL; Hou XF; Wirth GJ; Lu J
Chin Med J (Engl); 2021 Jun; 134(13):1576-1583. PubMed ID: 34133352
[TBL] [Abstract][Full Text] [Related]
23. Tissue-based Genomics Augments Post-prostatectomy Risk Stratification in a Natural History Cohort of Intermediate- and High-Risk Men.
Ross AE; Johnson MH; Yousefi K; Davicioni E; Netto GJ; Marchionni L; Fedor HL; Glavaris S; Choeurng V; Buerki C; Erho N; Lam LL; Humphreys EB; Faraj S; Bezerra SM; Han M; Partin AW; Trock BJ; Schaeffer EM
Eur Urol; 2016 Jan; 69(1):157-65. PubMed ID: 26058959
[TBL] [Abstract][Full Text] [Related]
24. Histological comparison between predictive value of preoperative 3-T multiparametric MRI and
Franklin A; Yaxley WJ; Raveenthiran S; Coughlin G; Gianduzzo T; Kua B; McEwan L; Wong D; Delahunt B; Egevad L; Samaratunga H; Brown N; Parkinson R; Roberts MJ; Yaxley JW
BJU Int; 2021 Jan; 127(1):71-79. PubMed ID: 32524748
[TBL] [Abstract][Full Text] [Related]
25. Stability of Prognostic Estimation Using the CAPRA Score Incorporating Imaging-based vs Physical Exam-based Staging.
Chang K; Greenberg SA; Cowan JE; Parker R; Shee K; Washington SL; Nguyen HG; Shinohara K; Carroll PR; Cooperberg MR
J Urol; 2023 Aug; 210(2):281-289. PubMed ID: 37099018
[TBL] [Abstract][Full Text] [Related]
26. Multiparametric Magnetic Resonance Imaging Is an Independent Predictor of Salvage Radiotherapy Outcomes After Radical Prostatectomy.
Sharma V; Nehra A; Colicchia M; Westerman ME; Kawashima A; Froemming AT; Kwon ED; Mynderse LA; Karnes RJ
Eur Urol; 2018 Jun; 73(6):879-887. PubMed ID: 29195777
[TBL] [Abstract][Full Text] [Related]
27. Prediction model for early biochemical recurrence after radical prostatectomy based on the Cancer of the Prostate Risk Assessment score and the presence of secondary circulating prostate cells.
Murray NP; Aedo S; Reyes E; Orellana N; Fuentealba C; Jacob O
BJU Int; 2016 Oct; 118(4):556-62. PubMed ID: 26507242
[TBL] [Abstract][Full Text] [Related]
28. Prostate Surface Distension and Tumor Texture Descriptors From Pre-Treatment MRI Are Associated With Biochemical Recurrence Following Radical Prostatectomy: Preliminary Findings.
Shiradkar R; Ghose S; Mahran A; Li L; Hubbard I; Fu P; Tirumani SH; Ponsky L; Purysko A; Madabhushi A
Front Oncol; 2022; 12():841801. PubMed ID: 35669420
[TBL] [Abstract][Full Text] [Related]
29. Validation of the Decipher Test for predicting adverse pathology in candidates for prostate cancer active surveillance.
Kim HL; Li P; Huang HC; Deheshi S; Marti T; Knudsen B; Abou-Ouf H; Alam R; Lotan TL; Lam LLC; du Plessis M; Davicioni E; Fleshner N; Lane BR; Ross AE; Davis JW; Mohler JL; Trock BJ; Klein EA; Tosoian JJ; Hyndman ME; Bismar TA
Prostate Cancer Prostatic Dis; 2019 Sep; 22(3):399-405. PubMed ID: 30542054
[TBL] [Abstract][Full Text] [Related]
30. A Novel Nomogram to Identify Candidates for Extended Pelvic Lymph Node Dissection Among Patients with Clinically Localized Prostate Cancer Diagnosed with Magnetic Resonance Imaging-targeted and Systematic Biopsies.
Gandaglia G; Ploussard G; Valerio M; Mattei A; Fiori C; Fossati N; Stabile A; Beauval JB; Malavaud B; Roumiguié M; Robesti D; Dell'Oglio P; Moschini M; Zamboni S; Rakauskas A; De Cobelli F; Porpiglia F; Montorsi F; Briganti A
Eur Urol; 2019 Mar; 75(3):506-514. PubMed ID: 30342844
[TBL] [Abstract][Full Text] [Related]
31. The Incremental Role of Magnetic Resonance Imaging for Prostate Cancer Staging before Radical Prostatectomy.
Morlacco A; Sharma V; Viers BR; Rangel LJ; Carlson RE; Froemming AT; Karnes RJ
Eur Urol; 2017 May; 71(5):701-704. PubMed ID: 27576750
[TBL] [Abstract][Full Text] [Related]
32. External validation of University of California, San Francisco, Cancer of the Prostate Risk Assessment score.
Zhao KH; Hernandez DJ; Han M; Humphreys EB; Mangold LA; Partin AW
Urology; 2008 Aug; 72(2):396-400. PubMed ID: 18372031
[TBL] [Abstract][Full Text] [Related]
33. Risk assessment of metastatic recurrence in patients with prostate cancer by using the Cancer of the Prostate Risk Assessment score: results from 2937 European patients.
Budäus L; Isbarn H; Tennstedt P; Salomon G; Schlomm T; Steuber T; Haese A; Chun F; Fisch M; Michl U; Heinzer H; Huland H; Graefen M
BJU Int; 2012 Dec; 110(11):1714-20. PubMed ID: 22520619
[TBL] [Abstract][Full Text] [Related]
34. Risk assessment for prostate cancer metastasis and mortality at the time of diagnosis.
Cooperberg MR; Broering JM; Carroll PR
J Natl Cancer Inst; 2009 Jun; 101(12):878-87. PubMed ID: 19509351
[TBL] [Abstract][Full Text] [Related]
35. Head-to-head comparison between multiparametric MRI, the partin tables, memorial sloan kettering cancer center nomogram, and CAPRA score in predicting extraprostatic cancer in patients undergoing radical prostatectomy.
Zanelli E; Giannarini G; Cereser L; Zuiani C; Como G; Pizzolitto S; Crestani A; Valotto C; Ficarra V; Girometti R
J Magn Reson Imaging; 2019 Nov; 50(5):1604-1613. PubMed ID: 30957321
[TBL] [Abstract][Full Text] [Related]
36. Multiinstitutional validation of the UCSF cancer of the prostate risk assessment for prediction of recurrence after radical prostatectomy.
Cooperberg MR; Freedland SJ; Pasta DJ; Elkin EP; Presti JC; Amling CL; Terris MK; Aronson WJ; Kane CJ; Carroll PR
Cancer; 2006 Nov; 107(10):2384-91. PubMed ID: 17039503
[TBL] [Abstract][Full Text] [Related]
37. Preoperative Multiparametric Magnetic Resonance Imaging Predicts Biochemical Recurrence in Prostate Cancer after Radical Prostatectomy.
Ho R; Siddiqui MM; George AK; Frye T; Kilchevsky A; Fascelli M; Shakir NA; Chelluri R; Abboud SF; Walton-Diaz A; Sankineni S; Merino MJ; Turkbey B; Choyke PL; Wood BJ; Pinto PA
PLoS One; 2016; 11(6):e0157313. PubMed ID: 27336392
[TBL] [Abstract][Full Text] [Related]
38. Genetic predisposition to early recurrence in clinically localized prostate cancer.
Borque Á; del Amo J; Esteban LM; Ars E; Hernández C; Planas J; Arruza A; Llarena R; Palou J; Herranz F; Raventós CX; Tejedor D; Artieda M; Simon L; Martínez A; Carceller E; Suárez M; Allué M; Sanz G; Morote J
BJU Int; 2013 Apr; 111(4):549-58. PubMed ID: 22759231
[TBL] [Abstract][Full Text] [Related]
39. Efficacy of post-operative radiation in a prostatectomy cohort adjusted for clinical and genomic risk.
Ross AE; Den RB; Yousefi K; Trock BJ; Tosoian J; Davicioni E; Thompson DJ; Choeurng V; Haddad Z; Tran PT; Trabulsi EJ; Gomella LG; Lallas CD; Abdollah F; Feng FY; Klein EA; Dicker AP; Freedland SJ; Karnes RJ; Schaeffer EM
Prostate Cancer Prostatic Dis; 2016 Sep; 19(3):277-82. PubMed ID: 27136742
[TBL] [Abstract][Full Text] [Related]
40. Cancer of the Prostate Risk Assessment (CAPRA) Preoperative Score Versus Postoperative Score (CAPRA-S): ability to predict cancer progression and decision-making regarding adjuvant therapy after radical prostatectomy.
Seo WI; Kang PM; Kang DI; Yoon JH; Kim W; Chung JI
J Korean Med Sci; 2014 Sep; 29(9):1212-6. PubMed ID: 25246738
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
